Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study. [electronic resource]
Producer: 20111219Description: 2403-2410 p. digitalISSN:- 1569-8041
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- BRCA1 Protein -- biosynthesis
- Biomarkers, Tumor -- biosynthesis
- Carboplatin -- administration & dosage
- Carcinoma, Ovarian Epithelial
- Cisplatin -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Immunohistochemistry
- Middle Aged
- Neoplasm Staging
- Neoplasms, Glandular and Epithelial -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Prognosis
- Topotecan -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.